Advertisement
Australia markets closed
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • AUD/USD

    0.6516
    +0.0016 (+0.24%)
     
  • OIL

    83.06
    +0.25 (+0.30%)
     
  • GOLD

    2,333.20
    -5.20 (-0.22%)
     
  • Bitcoin AUD

    98,792.91
    -3,863.93 (-3.76%)
     
  • CMC Crypto 200

    1,390.77
    +8.19 (+0.59%)
     
  • AUD/EUR

    0.6080
    +0.0010 (+0.16%)
     
  • AUD/NZD

    1.0948
    +0.0006 (+0.06%)
     
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NASDAQ

    17,526.80
    +55.33 (+0.32%)
     
  • FTSE

    8,065.58
    +25.20 (+0.31%)
     
  • Dow Jones

    38,460.92
    -42.77 (-0.11%)
     
  • DAX

    18,034.43
    -54.27 (-0.30%)
     
  • Hang Seng

    17,300.68
    +99.41 (+0.58%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

HERBALIFE INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding 100,000 Investing In Herbalife Nutrition, Ltd. To Contact The Firm

NEW YORK, June 17, 2020 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Herbalife Nutrition Ltd. (“Herbalife” or the “Company”) (HLF).

If you invested in Herbalife stock or options and would like to discuss your legal rights, click here: www.faruqilaw.com/HLF. There is no cost or obligation to you.

You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com.

CONTACT:
FARUQI & FARUQI, LLP
685 Third Avenue, 26th Floor
New York, NY 10017
Attn: Richard Gonnello, Esq.
rgonnello@faruqilaw.com
Telephone: (877) 247-4292 or (212) 983-9330

ADVERTISEMENT

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.